Stryker price target raised to $335 from $310 at Argus

Argus analyst David Toung raised the firm’s price target on Stryker to $335 from $310 and keeps a Buy rating on the shares after its Q3 earnings beat and guidance raise The analyst cites the company noting higher sales and margins, driven by the recovery in elective procedural volume and increased product supply. Argus is also raising its adjusted EPS estimates to $10.42 from $10.40 for 2023 and to $11.50 from $11.45 for 2024.